REGISTERED NUMBER: SC333815 (Scotland)

Financial Statements For The Year Ended 30 April 2025

for

CMAM Pharmacy Limited

Page

Company Information

1

Abridged Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs C Henry

Mrs A Duffy

REGISTERED OFFICE:

C/o Robb Ferguson

Regent Court

70 West Regent Street

Glasgow

G2 2QZ

REGISTERED NUMBER:

SC333815 (Scotland)

ACCOUNTANTS:

Robb Ferguson Chartered Accountants

Regent Court

70 West Regent Street

Glasgow

G2 2QZ

FIXED ASSETS

Intangible assets

4

538,625

608,125

Tangible assets

5

21,890

28,559

560,515

636,684

CURRENT ASSETS

Stocks

82,965

91,977

Debtors

250,399

253,896

Cash at bank and in hand

387,670

432,939

721,034

778,812

CREDITORS

Amounts falling due within one year

576,593

649,447

NET CURRENT ASSETS

144,441

129,365

TOTAL ASSETS LESS CURRENT LIABILITIES

704,956

766,049

CREDITORS

Amounts falling due after more than one year

6

(188,147

)

(274,265

)

PROVISIONS FOR LIABILITIES

-

(1,452

)

NET ASSETS

516,809

490,332

CAPITAL AND RESERVES

Called up share capital

2,000

2,000

Retained earnings

514,809

488,332

SHAREHOLDERS' FUNDS

516,809

490,332

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Comprehensive Income and an abridged Statement of Financial Position for the year ended 30 April 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2025 and were signed on its behalf by:

Mrs C Henry - Director

1.	STATUTORY INFORMATION

CMAM Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is stated net of VAT and trade discounts. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the value of the consideration due.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business, is being amortised evenly over its estimated useful life of twenty years. The directors are of the view that 20 years is the appropriate time frame for which to amortise the goodwill. The directors are of this view given the sector that the company operates in, where there is a ready market place for businesses like the one owned by the Company to be traded and where values have historically been resilient.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is shorter.

Leasehold Properties - 5% on cost

Fixed Plant & Equipment - 33.33% on cost and 20% on reducing balance

Computer Equipment - 33.33% on cost

Motor Vehicles - 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in the statement of comprehensive income. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in the statement of comprehensive income.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial positionstatement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the statement of financial position. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to the statement of comprehensive income over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to the statement of comprehensive income on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2024 - 17 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 May 2024

and 30 April 2025

1,390,000

AMORTISATION

At 1 May 2024

781,875

Amortisation for year

69,500

At 30 April 2025

851,375

NET BOOK VALUE

At 30 April 2025

538,625

At 30 April 2024

608,125

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 May 2024

and 30 April 2025

123,637

DEPRECIATION

At 1 May 2024

95,078

Charge for year

6,669

At 30 April 2025

101,747

NET BOOK VALUE

At 30 April 2025

21,890

At 30 April 2024

28,559

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals

£

COST

At 1 May 2024

and 30 April 2025

17,983

DEPRECIATION

At 1 May 2024

and 30 April 2025

4,496

NET BOOK VALUE

At 30 April 2025

13,487

At 30 April 2024

13,487

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE YEARS

2025

2024

£

£

Repayable by instalments

Bank loans more 5 yr by instal

93

5,648

7.	LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase

contracts

2025

2024

£

£

Net obligations repayable:

Within one year

3,597

3,597

Between one and five years

10,791

14,388

14,388

17,985

Non-cancellable

operating leases

2025

2024

£

£

Within one year

38,307

44,860

Between one and five years

23,100

61,407

61,407

106,267

8.	SECURED DEBTS

The following secured debts are included within creditors:

2025

2024

£

£

Bank loans

289,264

390,522

Hire purchase contracts

14,388

17,985

303,652

408,507

The Alliance & Leicester plc & Santander UK plc hold bonds and floating charges over all of the assets and undertakings of CMAM Pharmacy Ltd.

9.	ULTIMATE CONTROLLING PARTY

The company's ultimate parent company is CMAM Limited, a company incorporated in the UK.